Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma.
published in: The New England Journal of Medicine
date of publication: 2019-06-04
language: English
main subject: metastatic melanoma
Cites articles
There is nothing here
Article - wd:Q91013491